IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolism
Exp Hematol Oncol. 2025 Mar 1;14(1):25. doi: 10.1186/s40164-025-00612-z. ABSTRACT BACKGROUND: Acute myeloid leukemia (AML) is a prevalent malignancy of the hematologic system. Despite advancements in …